查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608044

多汗症治療市場：按類型、治療方法和最終用戶分類 - 全球預測 2025-2030

Hyperhidrosis Treatment Market by Type (Primary Hyperhidrosis, Secondary Generalized Hyperhidrosis), Treatment (Botulinum Toxin Injections, Microwave Therapy, Oral Medication), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年多汗症治療市值為6.1713億美元，預計到2024年將達到6.4788億美元，複合年成長率為6.70%，預計到2030年將達到9.7232億美元。

多汗症治療解決出汗過多的問題，出汗過多會因情緒、社交和職業困擾而影響個人的生活品質。市場需求是由於多汗症的盛行，影響了全球近 5% 的人口。治療方法包括局部用藥和內服藥物，以及肉毒桿菌注射、離子電滲透療法和手術切除術術等侵入性手術。典型的最終用途包括醫院、皮膚科診所和居家照護，反映了滿足患者個性化需求的各種應用。多汗症治療市場的成長是由於人們對現有治療方法、技術進步和 FDA核准的治療方法進入市場的認知的提高而推動的。此外，消費者對美容醫學信心的增強也顯著推動了需求。令人鼓舞的是，正在進行的臨床試驗和研發措施提供了新的機遇，特別是在開發副作用較少的非侵入性治療方面。該領域一個有前途的領域是擴展基於設備的治療，其具有持續療效和最短恢復時間的潛力。然而，由於治療成本高、潛在副作用以及缺乏廣泛使用（特別是在欠開發中地區），該方法也存在局限性。此外，與多汗症相關的恥辱限制了市場擴張，因為許多人不尋求治療。為了克服這些挑戰，公司可以專注於開發具有成本效益的創新解決方案。個人化治療，也許由穿戴式科技和人工智慧提供支持，可以使訪問民主化並提高患者的依從性。此外，建立遠端醫療服務作為一種有效的諮詢手段有可能進入滲透率較低的市場。市場的性質是動態的，隨著對非侵入性和患者友好型選擇的興趣日益濃厚，優先考慮以患者為中心的創新、協作醫療保健夥伴關係關係和有針對性的宣傳活動的公司將獲得回報，我們預計該市場將穩步擴大。

主要市場統計
基準年[2023] 61713萬美元
預計年份 [2024] 64788萬美元
預測年份 [2030] 97232萬美元
複合年成長率（%） 6.70%

市場動態：揭示快速發展的多汗症治療市場的關鍵市場洞察

多汗症治療市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 腋窩多汗症盛行率上升
    • 增加處方藥膏和擦拭巾的供應
    • 快速局部治療
  • 市場限制因素
    • 多汗症治療對健康的負面影響
  • 市場機會
    • 新療法和藥物介紹
    • 持續的研究活動和增加的核准
  • 市場挑戰
    • 缺乏認知和報銷政策問題

波特的五力：駕馭多汗症治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解多汗症治療市場的外在影響

外部宏觀環境因素在塑造多汗症治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解多汗症治療市場的競爭狀況

對多汗症治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣多汗症治療市場供應商的績效評估

FPNV定位矩陣是評估多汗症治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃多汗症治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對多汗症治療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腋窩多汗症盛行率增加
      • 可得性處方藥膏和擦拭用品的供應
      • 快速局部治療
    • 抑制因素
      • 多汗症治療對健康的負面影響
    • 機會
      • 新治療方法和藥物介紹
      • 增加正在進行的研究活動和核准
    • 任務
      • 缺乏意識和退款政策問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 多汗症治療市場：依類型

  • 原發性多汗症
  • 次發性多汗症

第7章 多汗症治療市場（依治療）

  • 肉毒毒素注射
  • 微波治療
  • 口腔醫學
  • 手術治療
  • 局部治療

第8章 多汗症治療市場：依最終用戶分類

  • 門診手術中心
  • 皮膚科診所
  • 付款人和患者

第9章北美和南美多汗症治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區多汗症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的多汗症治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Cynosure, LLC
  • Dermadry Laboratories Inc.
  • Dr. August Wolff GmbH & Co. KG
  • Eli Lilly and Company
  • Fresh Tracks Therapeutics, Inc.
  • GlaxoSmithKline PLC
  • Miramar Lab Inc.
  • Revance Therapeutics, Inc.
  • Sesderma, SL
  • TheraVida, Inc.
  • Ulthera, Inc. by Merz North America, Inc.
Product Code: MRR-5C438D4594DD

The Hyperhidrosis Treatment Market was valued at USD 617.13 million in 2023, expected to reach USD 647.88 million in 2024, and is projected to grow at a CAGR of 6.70%, to USD 972.32 million by 2030.

Hyperhidrosis treatment addresses excessive sweating issues, impacting individuals' quality of life due to emotional, social, and occupational distress. The market's necessity stems from the significant prevalence of hyperhidrosis, affecting nearly 5% of the global population. Treatments range from topical solutions and oral medications to more invasive procedures like Botox injections, iontophoresis, and surgical sympathectomy. Key end-use segments include hospitals, dermatology clinics, and home-care settings, reflecting the diverse applications that cater to personalized patient needs. The hyperhidrosis treatment market's growth is propelled by increased awareness about available therapies, technological advancements, and more FDA-approved treatments entering the market. Rising consumer willingness to spend on aesthetic procedures also significantly boosts demand. Encouragingly, ongoing clinical trials and R&D initiatives are presenting novel opportunities, particularly in developing non-invasive treatments with minimal side effects. A promising area within this field is the expansion of device-based treatments, which hold potential due to their lasting effects and minimal recovery time. However, limitations exist due to the high treatment costs, potential side effects, and lack of widespread accessibility, especially in less-developed regions. The stigma associated with hyperhidrosis also constrains market expansion, as many individuals may not seek treatment. To navigate these challenges, businesses can focus on developing cost-effective and innovative solutions, perhaps through wearable tech or AI-driven personalized treatments, which could democratize access and improve patient compliance. Moreover, establishing telemedicine services as an avenue for effective consultation could reach underpenetrated markets. With an ever-growing interest in non-invasive, patient-friendly options, the market's nature is dynamic and expected to expand steadily, rewarding companies that prioritize patient-centric innovations, collaborative healthcare partnerships, and targeted awareness campaigns.

KEY MARKET STATISTICS
Base Year [2023] USD 617.13 million
Estimated Year [2024] USD 647.88 million
Forecast Year [2030] USD 972.32 million
CAGR (%) 6.70%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hyperhidrosis Treatment Market

The Hyperhidrosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of axillary hyperhidrosis
    • Increasing availability of prescribed creams and wipe
    • Surg in adoption of topical treatment
  • Market Restraints
    • Adverse health impacts of hyperhidrosis treatment
  • Market Opportunities
    • Introduction of new therapeutics and drugs
    • Ongoing research activities and rising approvals
  • Market Challenges
    • Lack of awareness and reimbursement policies issues

Porter's Five Forces: A Strategic Tool for Navigating the Hyperhidrosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hyperhidrosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hyperhidrosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hyperhidrosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hyperhidrosis Treatment Market

A detailed market share analysis in the Hyperhidrosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hyperhidrosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hyperhidrosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hyperhidrosis Treatment Market

A strategic analysis of the Hyperhidrosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hyperhidrosis Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Cynosure, LLC, Dermadry Laboratories Inc., Dr. August Wolff GmbH & Co. KG, Eli Lilly and Company, Fresh Tracks Therapeutics, Inc., GlaxoSmithKline PLC, Miramar Lab Inc., Revance Therapeutics, Inc., Sesderma, S.L., TheraVida, Inc., and Ulthera, Inc. by Merz North America, Inc..

Market Segmentation & Coverage

This research report categorizes the Hyperhidrosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Primary Hyperhidrosis and Secondary Generalized Hyperhidrosis.
  • Based on Treatment, market is studied across Botulinum Toxin Injections, Microwave Therapy, Oral Medication, Surgical Treatment, and Topical Treatment.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Dermatology Clinics, and Payers & Patients.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of axillary hyperhidrosis
      • 5.1.1.2. Increasing availability of prescribed creams and wipe
      • 5.1.1.3. Surg in adoption of topical treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of hyperhidrosis treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of new therapeutics and drugs
      • 5.1.3.2. Ongoing research activities and rising approvals
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and reimbursement policies issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hyperhidrosis Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Primary Hyperhidrosis
  • 6.3. Secondary Generalized Hyperhidrosis

7. Hyperhidrosis Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Botulinum Toxin Injections
  • 7.3. Microwave Therapy
  • 7.4. Oral Medication
  • 7.5. Surgical Treatment
  • 7.6. Topical Treatment

8. Hyperhidrosis Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Dermatology Clinics
  • 8.4. Payers & Patients

9. Americas Hyperhidrosis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hyperhidrosis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hyperhidrosis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Cynosure, LLC
  • 3. Dermadry Laboratories Inc.
  • 4. Dr. August Wolff GmbH & Co. KG
  • 5. Eli Lilly and Company
  • 6. Fresh Tracks Therapeutics, Inc.
  • 7. GlaxoSmithKline PLC
  • 8. Miramar Lab Inc.
  • 9. Revance Therapeutics, Inc.
  • 10. Sesderma, S.L.
  • 11. TheraVida, Inc.
  • 12. Ulthera, Inc. by Merz North America, Inc.

LIST OF FIGURES

  • FIGURE 1. HYPERHIDROSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. HYPERHIDROSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HYPERHIDROSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HYPERHIDROSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HYPERHIDROSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HYPERHIDROSIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PRIMARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SECONDARY GENERALIZED HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY BOTULINUM TOXIN INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY MICROWAVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HYPERHIDROSIS TREATMENT MARKET SIZE, BY PAYERS & PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HYPERHIDROSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. HYPERHIDROSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. HYPERHIDROSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023